AMD 3100

JM 3100, SDZ SID 791

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

SDZ SID 791 (JM 3100): a mechanistically unique anti-HIV agent with potent antiviral activity in vitro and in vivo [abstract]. 10th International Conference on Aids; 1994 Aug 7–13; Yokohama, 1: 35
Google Scholar
Datema R, Rabin L, Hincenbergs M, et al. Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob Agents Chemother 1996 Mar; 40: 750–4
PubMed CAS Google Scholar
Donzella GA, Schols D, Lin SW, et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 1998 Jan; 4: 72–7
Article PubMed CAS Google Scholar
De Clercq E, Yamamoto N, Pauwels R, et al. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother 1994 Apr; 38: 668–74
Article PubMed Google Scholar
Esté JA, De Vreese K, Witvrouw M, et al. Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1. Antiviral Res 1996 Mar; 29 (No. 2–3): 297–307
Article PubMed Google Scholar
Esté JA, Schols D, Cabrera C, et al. Inhibition of HIV-1 replication by the bicyclam AMD3100, a CXCR4 antagonist. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997 Sep 28–Oct 1; Toronto, 255
Google Scholar

AMD 3100. Drugs R&D 2, 337–339 (1999). https://doi.org/10.2165/00126839-199902050-00012

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.